NCT05012033View on ClinicalTrials.gov

Evaluation of High Dose Prednisolone Pharmacokinetics in the Acute and Chronic Setting

RecruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

April 12, 2023

Primary Completion Date

March 26, 2026

Study Completion Date

March 26, 2026

Conditions
Thyroid Eye DiseaseVasculitisCOPD Exacerbation AcuteAsthmaInflammatory Disease
Interventions
OTHER

No intervention - prednisolone is taken as part if routine clinical care.

Prednisolone given orally prior to taking timed samples for levels

Trial Locations (1)

Unknown

RECRUITING

Imperial College Healthcare NHS Trust, London

All Listed Sponsors
lead

Imperial College London

OTHER